Skadden Arps Slate Meagher & Flom, Allen & Overy (A&O) and Sidley Austin are among the firms to have taken roles on German pharmaceutical company Merck’s $17bn (£10.5bn) acquisition of US laboratory supplies business Sigma-Aldrich.
Merck turned to Skadden as lead corporate advisers, which was announced last week. The firm is fielding a team that includes London-based M&A partner Hilary Foulkes, New York partners Peter Atkins and Neil Stronski and Frankfurt partner Katja Kaulamo.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]